Calyxt to Break Ground on New Concept-to-Fork Facility in Roseville, Minn.
September 06 2017 - 6:42PM
Business Wire
Following a successful initial public offering (IPO) in July
2017, Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and
agriculture-focused company, today announced that the Company will
break ground on its new concept-to-fork facility in Roseville,
Minn., on Thursday, Sept. 7, 2017, at 9 a.m. CT. The 11-acre site
will house Calyxt’s nearly 40,000-square-foot Company headquarters,
state-of-the-art research labs and test kitchen. The new
construction will be adjacent to the recently completed
11,000+-square-foot greenhouses and the existing outdoor
demonstration plots.
“This groundbreaking marks a pivotal moment in the history of
Calyxt, as the new facility has been specifically designed to
bolster scientific innovation when it comes to creating the
next-generation of healthy foods for consumers,” said Federico
Tripodi, Calyxt CEO. “Additionally, the facility will not only
further engrain Calyxt into the Minnesota agriculture community,
but it will also enable us to accelerate the development of our
growing pipeline and inch us closer to our first commercialized
product, the high-oleic soybean, in 2018.”
Calyxt has partnered with a developer to custom-build the new
facility, and completion is planned for the spring of 2018. This
facility will further support Calyxt’s growth plans for increased
process automation and staff expansion to up to 100 employees,
including new recruits for a variety of positions—from scientists
to commercial personnel—at the Company.
About Calyxt
Calyxt, Inc. is a consumer-centric, food- and
agriculture-focused company. By combining its leading gene-editing
technology and technical expertise with its innovative commercial
strategy, Calyxt is pioneering a paradigm shift to deliver
healthier food ingredients, such as healthier oils and high fiber
wheat, for consumers and agriculturally advantageous crop traits,
such as herbicide tolerance, for farmers. Calyxt is located in
Minneapolis-St. Paul, Minn., and is a wholly owned subsidiary of
Cellectis.
For further information please visit our website:
www.calyxt.comCalyxt™ and the corporate logo are trademarks owned
by Calyxt, Inc.
Talking about gene editing? We do it.TALEN® is a registered
trademark owned by the Cellectis Group.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170906006840/en/
For further information, please contact:For
CalyxtMedia contactsJennifer Moore, 917-580-1088VP
Communicationscontact@calyxt.comorKCSA Strategic
CommunicationsCaitlin Kasunich / Nick Opich, 212-896-1241 /
212-896-1206ckasunich@kcsa.com /
nopich@kcsa.comorInvestor Relations contactSimon Harnest,
646-385-9008VP Corporate Strategy and
Financesimon.harnest@cellectis.com
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From Apr 2023 to Apr 2024